Crossmark

Morbid Obesity Increases 30-Day Readmission and Morbidity in Clostridiodes difficile Infection

Published Online: 2021-02-05

Published Print: 2021-05

Authors

Dolan, Russell D.

Abougergi, Marwan S.

Schulman, Allison R. https://orcid.org/0000-0002-3913-8045
License Information

Text and Data Mining valid from 2021-02-05

Version of Record valid from 2021-02-05
More Information

Article History

Received: 22 October 2020

Revised: 19 January 2021

Accepted: 20 January 2021

First Online: 5 February 2021

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. Informed consent does not apply.

: Russell D. Dolan: No conflicts of interest to report.Marwan S. Abougergi: No conflicts of interest to report.Allison R. Schulman: Apollo Endosurgery (consultant), Boston Scientific (consultant), MicroTech (consultant) and GI Dynamics (research, grant support)

Document is current